Kevin Coleman
Vice President of Investor Relations and Treasurer
Replay available
AMETEK, Inc. (NYSE: AME) Q2 2025 earnings conference call, held 2025-07-31. Replay captured from the company's public earnings webcast.

Vice President of Investor Relations and Treasurer
Chairman and Chief Executive Officer
Executive Vice President and Chief Financial Officer
Analyst, RBC Capital Markets
Analyst, Vertical Research Partners
Analyst, Truist Securities
Analyst, DA Davidson
Analyst, Morgan Stanley
Analyst, Bank of America
Analyst, Mizuho Securities
Analyst, Oppenheimer & Co.
Analyst, KeyBank Capital Markets
Analyst, Wolf Research
Analyst, Seaport Research Partners
Hello, and welcome to Alma Tech's second quarter 2025 earnings conference call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask the question during the session, you would need to press star 11 on your telephone. You would then hear an automated message advising your hand is raised. To withdraw your question, please press star 11 again. I will now like to turn the conference over to Kevin Coleman, Vice President of Investor Relations and Treasurer. Sir, you may begin. Thank you, Tawanda. Good morning and welcome to Amatek's second quarter 2025 earnings conference call. Joining me today are Dave Zepico, Chairman and Chief Executive Officer, and Dala Puri, Executive Vice President and Chief Financial Officer. During the course of today's call, We will be making forward-looking statements which are subject to change based on various risk factors and uncertainties that may cause actual results to differ significantly from expectations. A detailed discussion of the risk and uncertainties that may affect our future results is contained in AMETEC's filings with the SEC. AMETEC disclaims any intention or obligation to update or revise any forward-looking statements. Any references made on this call 2024 or 2025 results will be on an adjusted basis, excluding after-tax acquisition-related intangible amortization and excluding the pre-tax $29.2 million for 10-cent-polluted share charge in the first quarter of 2024 for integration costs related to the Paragon Medical acquisition. Reconciliations between GAAP and adjusted measures can be found in our press release and on the investor section of our website. We'll begin today's call with prepared remarks, and then we'll open it up for y...